focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Regulatory News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.00
Bid: 3.30
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 1.20 (36.364%)
Open: 4.00
High: 0.00
Low: 0.00
Prev. Close: 4.00
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Correction : Holding(s) in Company

26 Feb 2009 11:09

This announcement replaces the announcement released 26 February at 09.00. In the announcement released at 09.00, the Sanofi-Aventis interest holdings was incorrectly stated as having crossed the 9% threshold. The correct threshold crossed is 10%

For filings with the FSA include the annex For filings with issuer exclude the annex TR-1: Notifications of Major Interests in Shares 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Proteome Sciences plc 2. Reason for notification [Yes/No] An acquisition or disposal of voting rights Yes An acquisition or disposal of financial instruments which No may result in the acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights No Other (please specify): No

3. Full name of person(s) subject to Sanofi-Aventis Deutschland GmbH notification

obligation: 4. Full name of shareholder(s) (if different from 3): 5. Date of transaction (and date on 24 February 2009 which the threshold is crossed or reached if different): 6. Date on which issuer notified: 25 February 2009 7. Threshold(s) that is/are crossed or 10.00% reached: 8: Notified Details A: Voting rights attached to shares Class/type of Situation previous to Resulting situation after shares the triggering the triggering transaction transaction If possible Number of Number of Number of Number of Percentage of use shares voting shares voting rights voting rights ISIN code rights Direct Indirect Direct Indirect GB003104196 13,663,380 13,663,380 12,286,187 12,286,187 9.25% B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration Exercise/ No. of voting Percentage of financial date conversion rights that may be voting rights instrument period/date acquired (if the instrument exercised/ converted) Total (A+B) Number of voting rights Percentage of voting rights 12,286,187 9.25%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Proxy Voting: 10. Name of proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: 14 Contact name: James Malthouse 15. Contact telephone name: +44 1932 865065

vendor
Date   Source Headline
29th Sep 20167:00 amRNSHolding(s) in Company
22nd Sep 20167:00 amRNSPublication: Journal of Alzheimer's disease
15th Sep 20167:00 amRNSHalf-year Report
28th Jul 20167:00 amRNSTrading Update and Notice of Results
24th Jun 201612:30 pmRNSAGM Statement and Result of AGM
1st Jun 20167:00 amRNSAppointment of CEO
31st May 20163:20 pmRNSPublication of Annual Report
18th May 20167:01 amRNSCEO Appointment
18th May 20167:00 amRNSPreliminary Results
5th Apr 20167:00 amRNSDeep Protein Profiling Key re. Cancer Treatment
1st Apr 20168:04 amRNSBlock Admission return
29th Feb 20167:00 amRNSTrading Update
5th Jan 20169:43 amRNSDirector Dealing
14th Dec 20154:02 pmRNSDirector Dealing
14th Dec 20159:36 amRNSHolding(s) in Company
5th Nov 20157:00 amRNSClinical Trial Results for CK1d
1st Oct 20157:00 amRNSBlock Admission return
30th Sep 20157:00 amRNSUnaudited Interim Results
4th Sep 20157:00 amRNSChange of Adviser
17th Jul 201512:01 pmRNSAGM Statement
13th Jul 20152:48 pmRNSHolding(s) in Company
3rd Jul 20155:03 pmRNSHolding(s) in Company
23rd Jun 20157:05 amRNSPublication of Annual Report
23rd Jun 20157:00 amRNSPlacing to raise £2.5 million
29th May 20157:00 amRNSPreliminary results
30th Mar 20154:21 pmRNSBlocklisting Interim Review
9th Mar 20157:00 amRNSTrading Statement
1st Dec 20143:15 pmRNSDirectorate Change
28th Nov 20147:00 amRNSSysQuant - Update/Contract Awards
19th Nov 20145:08 pmRNSHolding(s) in Company
12th Nov 20147:00 amRNSTrading Update
16th Oct 20147:00 amRNSDirectorate Change
1st Oct 20143:54 pmRNSDirector/PDMR Shareholding
30th Sep 20147:01 amRNSBlocklisting Interim Review
30th Sep 20147:00 amRNSDirectorate Change
30th Sep 20147:00 amRNSHalf Yearly Report
26th Sep 20147:00 amRNSCK1d Update: Toxicity Results
25th Sep 201410:08 amRNSContract with Genting TauRx Diagnostic Centre
15th Sep 20147:00 amRNSScience and Technology Award
19th Aug 20147:00 amRNSAppointment of Joint Broker
8th Jul 20145:45 pmRNSDirector/PDMR Shareholding
8th Jul 20147:00 amRNSAlzheimer's blood test study
1st Jul 20147:00 amRNSDirectorate Change
30th Jun 20144:42 pmRNSResult of AGM
9th Jun 20144:18 pmRNSAnnual Financial Report
29th May 20147:00 amRNSPreliminary results
1st Apr 20147:00 amRNSBlocklisting Interim Review
27th Mar 20147:00 amRNSPancreatic Cancer Study in PLOS ONE
3rd Mar 20144:25 pmRNSDirectorate Change
28th Feb 20143:46 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.